Global Medical Affairs Leader (GMAL), Lung

At Johnson & Johnson,we believe health is everything.

Our strength in healthcare innovation empowers us to build aworld where complex diseases are prevented, treated, and cured,where treatments are smarter and less invasive, andsolutions are personal.Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity.Learn more at jnj.com

As guided by Our Credo, Johnson & Johnson is responsible to our employees who work with us throughout the world.

We provide an inclusive work environment where each person is considered as an individual.

At Johnson & Johnson, we respect the diversity and dignity of our employees and recognize their merit.

Job Function:
Medical Affairs Group

Job Sub Function:
Medical Affairs

Job Category:
Scientific/Technology

All Job Posting Locations:
Raritan, New Jersey, United States of America

Job Description:

Johnson & Johnson Innovative Medicine is recruiting for a Global Medical Affairs Leader for Lung.

The preferred location for this position is Raritan, NJ.

About Innovative Medicine

Our expertise in Innovative Medicine is informed and inspired by patients, whose insights fuel our science-based advancements.

Visionaries like you work on teams that save lives by developing the medicines of tomorrow.

Join us in developing treatments, finding cures, and pioneering the path from lab to life while championing patients every step of the way.

Learn more at https://www.jnj.com/innovative-medicine

The Global Medical Affairs Lead (GMAL) for Lung Cancer will be responsible for leading aspects of the clinical-commercial optimization for EGFR-cMET assets in development and life cycle management strategies.

As the leader of the WWMAST (Worldwide Medical Affairs Strategy team), the GMAL will work with the Regional Medical Affairs Leaders in addressing data gaps and building confidence to ensure the most optimal and safe use of amivantamab and lazertinib and maximize the benefit for patients.

The GMAL will partner closely with the GMA Operations Leader, Marketing and Market access leader, Regional Medical TA/product leaders and Clinical Development Leader to develop an integrated global medical affairs perspectives, strategies and plans.

The GMAL will partner with the regions and the extended medical affairs partners for the development of the global Medical Affairs Strategic plan (WWMAS) that reflects the medical strategy and prioritized needs.

In addition, the WWMAST, led by the GMAL will develop the Integrated Evidence Generation plan, Global Publication plans, Global Opinion Leader relations, Global Medical Education plans and Content, and will be in charge of an overall
strategy for optimal Insights gathering.

The GMAL partner with the Global Commercial and Market Access Leads to develop the Global asset plan and be part of the Global Commercial Team (GC...